Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Bandak

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Clinical Genitourinary Cancer|August 16, 2016
Preorchiectomy Leydig Cell Dysfunction in Patients With Testicular CancerMikkel Bandak, Niels Jørgensen, Anders Juul, et al.
BMC Cancer|July 5, 2017
A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)Mikkel Bandak, Niels Jørgensen, Anders Juul, et al.
The Journal of Urology|May 7, 2018
Sexual Function in a Nationwide Cohort of 2,260 Survivors of Testicular Cancer after 17 Years of FollowupMikkel Bandak, Jakob Lauritsen, Christoffer Johansen, et al.
Acta Oncologica (Stockholm, Sweden)|April 5, 2021
Oncological outcome and complications of post-chemotherapy retroperitoneal surgery in non-seminomatous germ cell tumours - a systematic reviewJosephine J Rosenvilde, Gyrithe L Pedersen, Mikkel Bandak, et al.
European Urology Focus|November 29, 2018
Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular CancerMikkel Bandak, Jakob Lauritsen, Christoffer Johansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and CisplatinJakob Lauritsen, Maria Gry Gundgaard Kier, Mikkel Bandak, et al.
International Journal of Cancer|March 2, 2026
Risk of childhood and adolescent, and young adult cancer in offspring of men with testicular cancer: A Danish nationwide studyMikkel Bandak, Susanne Rosthøj, Gitte Lerche Aalborg, et al.
Andrology|February 19, 2026
A Unified Machine Learning Model for Relapse Prediction in Clinical Stage I Testicular CancerThomas Wagner, Ramtin Zargari Marandi, Jakob Lauritsen, et al.
Journal of Insurance Medicine (New York, N.Y.)|March 1, 2018
Relapse and Mortality Risk of Stage I Testicular CancerCecilia Florvall, Peder Frederiksen, Jakob Lauritsen, et al.
JNCI Cancer Spectrum|July 4, 2020
Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer PatientsSara L Garcia, Jakob Lauritsen, Zeyu Zhang, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Clinical Genitourinary Cancer|August 16, 2016
Preorchiectomy Leydig Cell Dysfunction in Patients With Testicular CancerMikkel Bandak, Niels Jørgensen, Anders Juul, et al.
BMC Cancer|July 5, 2017
A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)Mikkel Bandak, Niels Jørgensen, Anders Juul, et al.
The Journal of Urology|May 7, 2018
Sexual Function in a Nationwide Cohort of 2,260 Survivors of Testicular Cancer after 17 Years of FollowupMikkel Bandak, Jakob Lauritsen, Christoffer Johansen, et al.
Acta Oncologica (Stockholm, Sweden)|April 5, 2021
Oncological outcome and complications of post-chemotherapy retroperitoneal surgery in non-seminomatous germ cell tumours - a systematic reviewJosephine J Rosenvilde, Gyrithe L Pedersen, Mikkel Bandak, et al.
European Urology Focus|November 29, 2018
Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular CancerMikkel Bandak, Jakob Lauritsen, Christoffer Johansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and CisplatinJakob Lauritsen, Maria Gry Gundgaard Kier, Mikkel Bandak, et al.
International Journal of Cancer|March 2, 2026
Risk of childhood and adolescent, and young adult cancer in offspring of men with testicular cancer: A Danish nationwide studyMikkel Bandak, Susanne Rosthøj, Gitte Lerche Aalborg, et al.
Andrology|February 19, 2026
A Unified Machine Learning Model for Relapse Prediction in Clinical Stage I Testicular CancerThomas Wagner, Ramtin Zargari Marandi, Jakob Lauritsen, et al.
Journal of Insurance Medicine (New York, N.Y.)|March 1, 2018
Relapse and Mortality Risk of Stage I Testicular CancerCecilia Florvall, Peder Frederiksen, Jakob Lauritsen, et al.
JNCI Cancer Spectrum|July 4, 2020
Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer PatientsSara L Garcia, Jakob Lauritsen, Zeyu Zhang, et al.
Pageof 5